Diabetes mellitus is associated with increased oxidative stress and disturbances in hepatic metabolism, which may contribute to hepatocellular dysfunction. Epicatechin, a naturally occurring flavonoid, has demonstrated antioxidant and metabolic regulatory properties in previous experimental studies. The present study aimed to investigate the potential protective effects of epicatechin against oxidative stress and biochemical alterations in the liver of rats with experimental diabetes. White Wistar rats were used to establish an experimental diabetes model, followed by epicatechin administration. The effects of treatment were evaluated using biochemical and oxidative stress-related parameters, including malondialdehyde (MDA), superoxide dismutase (SOD), reduced glutathione (GSH), lactate dehydrogenase (LDH), alanine aminotransferase (ALT), and aspartate aminotransferase (AST). Blood glucose levels and selected hepatic biochemical parameters were also assessed to characterize metabolic alterations. Epicatechin administration was associated with attenuation of oxidative stress, reflected by improved SOD and GSH status and reduced MDA levels. Improvements in hepatic marker enzymes, including ALT, AST, and LDH, as well as blood glucose levels, were also observed compared with the diabetic control group. These findings suggest that epicatechin may exert a protective effect against diabetes-associated hepatic dysfunction, potentially through attenuation of oxidative stress and improvement of metabolic homeostasis. The findings provide a basis for further investigations, including complementary in vitro studies, to clarify the cellular effects and mechanisms underlying the observed protective activity of epicatechin.